Investing.com - Alpine Immune Sciences (NASDAQ: ALPN) reported first quarter EPS of $-0.280, $0.03 better than the analyst estimate of $-0.310. Revenue for the quarter came in at...
Alpine Immune Sciences (NASDAQ:ALPN) has filed $400,000,000 mixed shelf of:Common StockPreferred StockDebt SecuritiesDepositary SharesWarrantsSubscription RightsPurchase...
Investing.com - Alpine Immune Sciences (NASDAQ: ALPN) reported first quarter EPS of $-0.410, $0.15 worse than the analyst estimate of $-0.260. Revenue for the quarter came in at...
Is it a trend? A sign of the times? Or both? What I am referring to are share buybacks. Talk on Wall Street this week included a whole lot of conversations about share buybacks....
Every year World Arthritis Day is observed on Oct 12 to raise awareness on the disease’s far-reaching impact on patients across the globe. On this day, several...
Alpine Immune Sciences (NASDAQ:ALPN), Inc. ALPN shares rallied 9.5% in the last trading session to close at $15.03. This move can be attributable to notable volume with a higher...
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. The Company's scientific platform uses a directed evolution process to convert native immune system proteins from the immunoglobulin super family (IgSF) into multi-targeted therapeutics capable of modulating the human immune system. The Company’s product candidates include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulator (ICOS) and cluster of differentiation 28 (CD28) antagonist intended for the treatment of autoimmune and inflammatory diseases. Its oncology program is ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor intended for the treatment of cancer. ALPN-303 is a dual B-cell cytokine antagonist for the treatment of B-cell mediated diseases.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Strong Sell | Neutral | Buy | Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Buy | Strong Buy |
| Summary | Strong Sell | Strong Sell | Sell | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 125.43 | 126.00 | 123.29 | +1.08 | +0.87% | 25.17M | NASDAQ | |||
| 3.66 | 3.805 | 3.585 | -0.100 | -2.66% | 362.28K | NASDAQ | |||
| 9.10 | 9.10 | 9.10 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 55.89 | 56.90 | 55.79 | -0.48 | -0.85% | 3.03M | NYSE | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 59.00 | 60.40 | 58.97 | -0.30 | -0.51% | 10.09M | NYSE | |||
| 21.96 | 22.17 | 21.80 | +0.01 | +0.05% | 11.31K | NYSE | |||
| 126.08 | 126.40 | 120.63 | +7.41 | +6.24% | 3.04M | NASDAQ | |||
| 4.44 | 4.76 | 4.20 | -0.400 | -8.26% | 272.84K | NASDAQ | |||
| 4.50 | 4.60 | 4.42 | +0.01 | +0.22% | 7.06M | NASDAQ | |||
| 23.90 | 24.10 | 23.50 | +0.29 | +1.23% | 1.73M | NYSE | |||
| 150.31 | 151.01 | 146.82 | +2.66 | +1.80% | 1.01M | NYSE | |||
| 10.28 | 10.40 | 9.84 | +0.50 | +5.11% | 20.39M | NYSE | |||
| 21.76 | 22.04 | 21.51 | +0.18 | +0.83% | 309.78K | NASDAQ | |||
| 8.38 | 8.41 | 8.30 | +0.040 | +0.48% | 1.15M | NYSE |